ZD-6021

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameZD-6021
Drug Alias NameZD-6021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 2 receptor antagonistsNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptorNeurokinin 2 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A